4.5 Review

Vitamin B12 status in health and disease: a critical review. Diagnosis of deficiency and insufficiency - clinical and laboratory pitfalls

Journal

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
Volume 58, Issue 6, Pages 399-429

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/10408363.2021.1885339

Keywords

Vitamin B-12; cobalamin holotranscobalamin methylmalonic acid homocysteine

Ask authors/readers for more resources

Vitamin B-12 is an essential cofactor in two metabolic pathways and is primarily obtained from animal-based foods. Deficiency in B-12 can mimic various illnesses and requires attention from different medical specialists for accurate diagnosis and treatment. Current tests and treatment options for B-12 deficiency have limitations that need to be addressed for better assessment and management.
Vitamin B-12 (cobalamin) is an essential cofactor for two metabolic pathways. It is obtained principally from food of animal origin. Cobalamin becomes bioavailable through a series of steps pertaining to its release from dietary protein, intrinsic factor-mediated absorption, haptocorrin or transcobalamin-mediated transport, cellular uptake, and two enzymatic conversions (via methionine synthase and methylmalonyl-CoA-mutase) into cofactor forms: methylcobalamin and adenosylcobalamin. Vitamin B-12 deficiency can masquerade as a multitude of illnesses, presenting different perspectives from the point of view of the hematologist, neurologist, gastroenterologist, general physician, or dietician. Increased physician vigilance and heightened patient awareness often account for its early presentation, and testing sometimes occurs during a phase of vitamin B-12 insufficiency before the main onset of the disease. The chosen test often depends on its availability rather than on the diagnostic performance and sensitivity to irrelevant factors interfering with vitamin B-12 markers. Although serum B-12 is still the most commonly used and widely available test, diagnostics by holotranscobalamin, serum methylmalonic acid, and plasma homocysteine measurements have grown in the last several years in routine practice. The lack of a robust absorption test, coupled with compromised sensitivity and specificity of other tests (intrinsic factor and gastric parietal cell antibodies), hinders determination of the cause for depleted B-12 status. This can lead to incorrect supplementation regimes and uncertainty regarding later treatment. This review discusses currently available knowledge on vitamin B-12, informs the reader about the pitfalls of tests for assessing its deficiency, reviews B-12 status in various populations at different disease stages, and provides recommendations for interpretation, treatment, and associated risks. Future directions for diagnostics of B-12 status and health interventions are also discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available